We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The Bone Metabolism Unit (UMO) focuses on detecting, treating, and monitoring patients with metabolic bone disorders. Our specialized care comprises pathologies ranging from osteoporosis, which is the most common of these disorders, to Paget's disease and osteomalacia, and includes rare diseases like osteogenesis imperfecta.
We concern ourselves with detecting, treating, and monitoring patients with premenopausal, postmenopausal, and male osteoporosis, along with osteoporosis that can appear secondary to drugs and other diseases, such as transplants, blood and endocrine diseases, HIV infection, bariatric surgery, breast cancer, and chronic kidney failure. These pathologies can, through various mechanisms, cause osteoporosis. That is why we actively monitor these patients, coordinating with the different specialities treating them.
In this line, we carry out important healthcare and research work in osteoporosis related to lung transplant, actively evaluating the patients and carrying out protocol-based, multidisciplinary treatment and follow-up to minimise the risk of fractures and avoid the associated complications. The fact that the Vall d'Hebron University Hospital is the only centre in Catalonia authorised to do lung transplants means that we have extensive healthcare activity and experience in this field.
The Fracture Liaison Unit (UCF) for the North Primary Health Care Area (AIS Nord) is in the process of being created and inaugurated. Fracture Liaison Units (FLS) are multidisciplinary services whose objective is the secondary prevention of fractures due to bone fragility (those produced by a light impact or mild fall). The first fragility fracture is a predictor for subsequent fractures and is associated with very high morbidity, mortality, and socioeconomic costs, especially when it is a hip fracture. Fracture Liaison Units have been implemented in many countries and there are many publications that substantiate their effectiveness and clinical potential (https://www.capturethefracture.org/). Thus, our objective is based on offering a patient who has suffered a first fragility fracture timely, comprehensive, protocol-based, and high-quality care.
In addition, we are actively involved in the less prevalent bone metabolism disorders, such as Paget's disease and osteomalacia, as well as rare disorders like osteogenesis imperfecta, which require coordinated care with different medical and surgical specialities and a close, multidisciplinary monitoring.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.